The cumulative incidence of NAION over 36 months was significantly higher in the semaglutide group (8.9%) compared to the non-GLP-1 RA group (1.8%)
Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, et al
The potential role of PP is further complicated by the discovery that the central administration of the peptide can induce moderate hyperphagia, potentially via actions on Y 5 receptors
these devices enable easy dose adjustment, allowing personalized treatment for conditions such as Type 2 Diabetes and Obesity, while offering intuitive functionality, improved dosing accuracy, and higher patient acceptance compared to fixed-dose systems, thereby driving their rapid adoption and growth
At Memorial Primary and Urgent Care, our team of healthcare professionals is dedicated to providing personalized care and guidance to help patients achieve their health and wellness objectives